MAPK1 and cancer: The inhibition of ERK phosphorylation could suppress cancer-stromal interactions in pancreatic cancer [27] and promote the ULK1 degradation process, leading to an improved invasive phenotype under hypoxia and osteolytic bone metastasis in BC cells induced by ULK1 deficiency [28].